Analyze Diet

Topic:Oral Administration

Oral administration in horses refers to the delivery of medications, supplements, or nutrients via the mouth. This method is commonly used in equine veterinary medicine for its practicality and ease of use. Oral formulations can include powders, pastes, or liquids, which are designed to be palatable and easily ingested by horses. The effectiveness of oral administration depends on factors such as the horse's digestive physiology, the formulation of the product, and the consistency with which it is administered. This page compiles peer-reviewed research studies and scholarly articles that explore the techniques, efficacy, and considerations of oral administration in equine care.
Evaluation of the humoral immune response and fecal shedding in weanling foals following oral and intra-rectal administration of an avirulent live vaccine of Lawsonia intracellularis.
Veterinary journal (London, England : 1997)    October 2, 2008   Volume 182, Issue 3 458-462 doi: 10.1016/j.tvjl.2008.08.016
Pusterla N, Hilton H, Wattanaphansak S, Collier JR, Mapes SM, Stenbom RM, Gebhart C.Equine proliferative enteropathy (EPE) caused by Lawsonia intracellularis has recently been recognized as an emerging disease in foals. Whilst the clinical entity, diagnostic evaluation and treatment of affected foals have been well established and described, preventive measures for EPE have remained largely unaddressed. The objectives of this study were to investigate the humoral immune response and onset and duration of fecal shedding in foals after oral and intra-rectal administration of a modified-live vaccine of L. intracellularis. Foals were vaccinated twice, 3 weeks apart, via oral dren...
Evaluation of orally administered valacyclovir in experimentally EHV1-infected ponies.
Veterinary microbiology    September 21, 2008   Volume 135, Issue 3-4 214-221 doi: 10.1016/j.vetmic.2008.09.062
Garré B, Gryspeerdt A, Croubels S, De Backer P, Nauwynck H.The purpose of the current study was to investigate the therapeutic efficacy of valacyclovir against EHV1 in a controlled study. Eight naïve Shetland ponies were inoculated with 10(6.5) TCID(50) of the neuropathogenic strain 03P37. Four ponies were treated with valacyclovir at a dosage of 40mg/kg bodyweight, 3 times daily, for 5 (n=2) or 7 (n=2) consecutive days, while the other four ponies served as untreated controls. The treatment regimen started 1h before inoculation. Ponies were monitored daily for clinical signs. At 0, 1, 2, 3, 4, 5, 7, 9, 11, 14, 17 and 21 days post inoculation (d pi),...
Joint inflammation increases glucosamine levels attained in synovial fluid following oral administration of glucosamine hydrochloride.
Osteoarthritis and cartilage    August 8, 2008   Volume 17, Issue 2 228-234 doi: 10.1016/j.joca.2008.06.018
Meulyzer M, Vachon P, Beaudry F, Vinardell T, Richard H, Beauchamp G, Laverty S.To compare synovial glucosamine levels in normal and inflamed equine joints following oral glucosamine administration and to determine whether single dose administration alters standard synovial parameters of inflammation. Methods: Eight adult horses were studied. On weeks 1 and 2, all horses received 20mg/kg glucosamine hydrochloride by nasogastric (NG) intubation or intravenous injection. On weeks 3 and 4, 12h after injection of both radiocarpal joints with 0.25 ng Escherichia coli lipopolysaccharide (LPS) to induce inflammation, glucosamine hydrochloride or a placebo was administered by NG ...
Pharmacokinetics of valacyclovir in the adult horse.
Journal of veterinary pharmacology and therapeutics    July 22, 2008   Volume 31, Issue 4 312-320 doi: 10.1111/j.1365-2885.2008.00957.x
Maxwell LK, Bentz BG, Bourne DW, Erkert RS.Recent outbreaks of equine herpes virus type-1 infections have stimulated renewed interest in the use of effective antiherpetic drugs in horses. The purpose of this study was to investigate the pharmacokinetics of valacyclovir (VCV), the prodrug of acyclovir (ACV), in horses. Six adult horses were used in a randomized cross-over design. Treatments consisted of 10 mg/kg ACV infused intravenously, 5 g (7.7-11.7 mg/kg) VCV delivered intragastrically (IG) and 15 g (22.7-34.1 mg/kg) VCV administered IG. Serum samples were obtained at predetermined times for acyclovir assay using high-performance li...
The prokinetic effect of mosapride citrate on horse gastric emptying rates.
The Journal of veterinary medical science    July 17, 2008   Volume 70, Issue 6 627-628 doi: 10.1292/jvms.70.627
Okamura K, Sasaki N, Fukunaka M, Yamada H, Inokuma H.The prokinetic effect of the 5-HT4 receptor agonist mosapride was evaluated in seven healthy thoroughbreds. Mosapride was orally administered at doses of 0.5, 1.0 or 1.5 mg/kg. The breath 13CO2/12CO2 rate (Delta13CO2), an indirect indicator for the rate of gastric emptying, was measured at appropriate points for 4 hr after drug administration. There was a significant increase compared with the control value at 15, 20 and 165 min for 0.5 mg/kg, 30 min at 1.0 mg/kg and 165 min for 1.5 mg/kg. The results suggest that mosapride may facilitate the gastric emptying in horses.
Evaluation of the palatability of three nonsteroidal antiinflammatory top-dress formulations in horses.
Veterinary therapeutics : research in applied veterinary medicine    July 4, 2008   Volume 9, Issue 2 122-127 
Longhofer SL, Reinemeyer CR, Radecki SV.The efficacy of top-dress antiinflammatory drugs ultimately depends on a patient's willingness to consume treated feed. The current study compares the palatability of two phenylbutazone top-dress formulations (Equipalazone Powder, Dechra Pharmaceuticals, and Pro-Dynam, VetXX, Ltd.) and a suxibuzone top-dress formulation (Danilon Equidos, Janssen Animal Health). Results of a three-period, crossover study on 18 healthy horses showed that Pro-Dynam was significantly less palatable, with significantly less consumption of treated feed compared with either Equipalazone Powder or Danilon Equidos. The...
Assessment of vitamin E concentrations in serum and cerebrospinal fluid of horses following oral administration of vitamin E.
American journal of veterinary research    June 4, 2008   Volume 69, Issue 6 785-790 doi: 10.2460/ajvr.69.6.785
Higgins JK, Puschner B, Kass PH, Pusterla N.To determine concentrations of alpha-tocopherol in serum and CSF of healthy horses following administration of supplemental vitamin E in feed. Methods: 10 healthy adult horses. Methods: Horses were allocated to receive supplemental d-alpha-tocopherol (1,000 U/d [group A; n=5] or 10,000 U/d [group B; 5]) in feed for 10 days. Blood samples were collected before (baseline), during, and at intervals for 10 days after discontinuation of vitamin E administration for assessment of serum alpha-tocopherol concentration. Cerebrospinal fluid samples were collected prior to and 24 hours after cessation of...
Pharmacokinetics of potassium bromide in adult horses.
Australian veterinary journal    May 6, 2008   Volume 86, Issue 5 187-193 doi: 10.1111/j.1751-0813.2007.00250.x
Raidal SL, Edwards S.To determine the pharmacokinetics of potassium bromide (KBr) in horses after a single and multiple oral doses. Methods: Twelve adult Standardbred and Thoroughbred mares. Methods: Horses were randomly assigned into two treatment groups. In Part 1 of the study, horses were given a single oral dose of 120 mg/kg KBr. Part 2 of the study evaluated a loading dose of 120 mg/kg KBr daily by stomach tube for 5 days, followed by 40 mg/kg daily in feed for 7 days. Serum concentrations of bromide were determined by colorimetric spectrophotometry following drug administration to permit determination of con...
Pharmacokinetics and effects of aminorex in horses.
American journal of veterinary research    May 2, 2008   Volume 69, Issue 5 675-681 doi: 10.2460/ajvr.69.5.675
Soma LR, Rudy JA, Uboh CE, Xu F, Snapp HM.To investigate the pharmacokinetics and behavioral effects of aminorex administered IV and PO in horses. Methods: 7 Thoroughbreds. Methods: In a cross-over design, aminorex (0.03 mg/kg) was administered IV or PO. Plasma and urinary aminorex concentrations were determined via liquid chromatography- mass spectrometry. Results: Decrease of aminorex from plasma following IV administration was described by a 3-compartment pharmacokinetic model. Median (range) values of alpha, beta, and gamma half-lives were 0.04 (0.01 to 0.28), 2.30 (1.23 to 3.09), and 18.82 (8.13 to 46.64) hours, respectively. Tot...
Retrospective study assessing efficacy of treatment of large colonic impactions.
Equine veterinary journal    March 7, 2008   Volume 40, Issue 4 411-413 doi: 10.2746/042516408X288282
Hallowell GD.Cases with a history of colic due to a large colonic impaction were recruited retrospectively to assess the treatment efficacy and complications of oral and parenteral fluid therapy regimes for correction of primary large colon impactions. Oral isotonic fluids had been administered at varying intervals following initial treatment with magnesium sulphate and water. There was no significant difference in complication rates between groups. Considering complication rates with impaction clearance, hourly administration of oral fluids appears to be the most appropriate treatment regime of those inve...
Comparison of pharmacokinetics of glucosamine and synovial fluid levels following administration of glucosamine sulphate or glucosamine hydrochloride.
Osteoarthritis and cartilage    March 4, 2008   Volume 16, Issue 9 973-979 doi: 10.1016/j.joca.2008.01.006
Meulyzer M, Vachon P, Beaudry F, Vinardell T, Richard H, Beauchamp G, Laverty S.To compare the pharmacokinetics of glucosamine and the synovial fluid levels attained following treatment with glucosamine sulphate or glucosamine hydrochloride in a large animal model at clinically relevant doses. Methods: Eight adult female horses were used. Crystalline glucosamine sulphate (Dona) or glucosamine hydrochloride was administered at a dose of 20 mg/kg by either intravenous (i.v.) injection or nasogastric (n.g.) intubation. Plasma samples were collected before dosing and at 5, 15, 30, 60, 120, 360, 480 and 720 min after dosing. Synovial fluid samples were collected from the radio...
Effect of intermittent oral administration of ponazuril on experimental Sarcocystis neurona infection of horses.
American journal of veterinary research    March 4, 2008   Volume 69, Issue 3 396-402 doi: 10.2460/ajvr.69.3.396
Mackay RJ, Tanhauser ST, Gillis KD, Mayhew IG, Kennedy TJ.To evaluate the effect of intermittent oral administration of ponazuril on immunoconversion against Sarcocystis neurona in horses inoculated intragastrically with S neurona sporocysts. Methods: 20 healthy horses that were seronegative for S neurona-specific IgG. Methods: 5 control horses were neither inoculated with sporocysts nor treated. Other horses (5 horses/group) each received 612,500 S neurona sporocysts via nasogastric tube (day 0) and were not treated or were administered ponazuril (20 mg/kg, PO) every 7 days (beginning on day 5) or every 14 days (beginning on day 12) for 12 weeks. Bl...
Effectiveness of administration of phenylbutazone alone or concurrent administration of phenylbutazone and flunixin meglumine to alleviate lameness in horses.
American journal of veterinary research    February 5, 2008   Volume 69, Issue 2 167-173 doi: 10.2460/ajvr.69.2.167
Keegan KG, Messer NT, Reed SK, Wilson DA, Kramer J.To determine the effectiveness of administering multiple doses of phenylbutazone alone or a combination of phenylbutazone and flunixin meglumine to alleviate lameness in horses. Methods: 29 adult horses with naturally occurring forelimb and hind limb lameness. Methods: Lameness evaluations were performed by use of kinematic evaluation while horses were trotting on a treadmill. Lameness evaluations were performed before and 12 hours after administration of 2 nonsteroidal anti-inflammatory drug (NSAID) treatment regimens. Phenylbutazone paste was administered at approximately 2.2 mg/kg, PO, ever...
Pharmacokinetics of tilmicosin in equine tissues and plasma.
Journal of veterinary pharmacology and therapeutics    January 8, 2008   Volume 31, Issue 1 66-70 doi: 10.1111/j.1365-2885.2007.00909.x
Clark C, Dowling PM, Ross S, Woodbury M, Boison JO.The macrolide antibiotic tilmicosin has potential for treating bacterial respiratory tract infections in horses. A pharmacokinetic study evaluated the disposition of tilmicosin in the horse after oral (4 mg/kg) or subcutaneous (s.c.) (10 mg/kg) administration. Tilmicosin was not detected in equine plasma or tissues after oral administration at this dose. With s.c. injection, tilmicosin concentrations reached a maximum concentration of approximately 200 ng/mL in the plasma of the horses. Tilmicosin concentrations in plasma persisted with a mean residence time (MRT) of 19 h. Maximum tissue resid...
Pharmacokinetics of tramadol in horses after intravenous, intramuscular and oral administration.
Journal of veterinary pharmacology and therapeutics    January 8, 2008   Volume 31, Issue 1 60-65 doi: 10.1111/j.1365-2885.2007.00929.x
Shilo Y, Britzi M, Eytan B, Lifschitz T, Soback S, Steinman A.Tramadol is a centrally acting analgesic drug that has been used clinically for the last two decades to treat moderate to moderately severe pain in humans. The present study investigated tramadol administration in horses by intravenous, intramuscular, oral as immediate-release and oral as sustained-release dosage-form routes. Seven horses were used in a four-way crossover study design in which racemic tramadol was administered at 2 mg/kg by each route of administration. Altogether, 23 blood samples were collected between 0 and 2880 min. The concentration of tramadol and its M1 metabolite were ...
Effects of long-term oral administration of levothyroxine sodium on serum thyroid hormone concentrations, clinicopathologic variables, and echocardiographic measurements in healthy adult horses.
American journal of veterinary research    January 3, 2008   Volume 69, Issue 1 68-75 doi: 10.2460/ajvr.69.1.68
Frank N, Buchanan BR, Elliott SB.To determine the effects of long-term oral levothyroxine sodium (L-T(4)) administration on serum thyroid hormone concentrations, thyroid gland function, clinicopathologic variables, and echocardiographic examination measurements in adult euthyroid horses. Methods: 6 healthy adult mares. Methods: Horses received L-T(4) (48 mg/d) orally for 48 weeks. Every 4 weeks, physical examinations were performed; blood samples were collected for CBC, plasma biochemical analyses, and assessments of serum total triiodothyronine (tT(3)) and thyroxine (tT(4)) concentrations. Plasma creatine kinase MB activity ...
Comparison of efficacy and safety of paste formulations of firocoxib and phenylbutazone in horses with naturally occurring osteoarthritis.
Journal of the American Veterinary Medical Association    January 3, 2008   Volume 232, Issue 1 91-97 doi: 10.2460/javma.232.1.91
Doucet MY, Bertone AL, Hendrickson D, Hughes F, Macallister C, McClure S, Reinemeyer C, Rossier Y, Sifferman R, Vrins AA, White G, Kunkle B, Alva R....To compare efficacy and safety of paste formulations of firocoxib and phenylbutazone in horses with naturally occurring osteoarthritis. Methods: Randomized controlled clinical trial. Methods: 253 client-owned horses with naturally occurring osteoarthritis. Methods: Horses were treated with firocoxib (0.1 mg/kg [0.045 mg/lb], PO, q 24 h) or phenylbutazone (4.4 mg/kg [2 mg/lb], PO, q 24 h) for 14 days. Physical examinations and lameness evaluations were performed prior to treatment and after 7 and 14 days. Clinical improvement was defined as a reduction of at least 1 lameness grade or a combined...
Effects of long-term oral administration of levothyroxine sodium on glucose dynamics in healthy adult horses.
American journal of veterinary research    January 3, 2008   Volume 69, Issue 1 76-81 doi: 10.2460/ajvr.69.1.76
Frank N, Elliott SB, Boston RC.To determine the effects of long-term oral administration of levothyroxine sodium (L-T(4)) on glucose dynamics in adult euthyroid horses. Methods: 6 healthy adult mares. Methods: Horses received L-T(4) (48 mg/d) orally for 48 weeks. Frequently sampled IV glucose tolerance test procedures were performed on 3 occasions (24-hour intervals) before and at 16, 32, and 48 weeks during the treatment period. Data were assessed via minimal model analysis. The repeatability of measurements was evaluated. Results: During treatment, body weight decreased significantly from the pretreatment value; mean +/- ...
The effect of oral sodium acetate administration on plasma acetate concentration and acid-base state in horses.
Acta veterinaria Scandinavica    December 20, 2007   Volume 49, Issue 1 38 doi: 10.1186/1751-0147-49-38
Waller A, Lindinger MI.Sodium acetate (NaAcetate) has received some attention as an alkalinizing agent and possible alternative energy source for the horse, however the effects of oral administration remain largely unknown. The present study used the physicochemical approach to characterize the changes in acid-base status occurring after oral NaAcetate/acetic acid (NAA) administration in horses. Methods: Jugular venous blood was sampled from 9 exercise-conditioned horses on 2 separate occasions, at rest and for 24 h following a competition exercise test (CET) designed to simulate the speed and endurance test of 3-da...
The effect of omeprazole paste on intragastric pH in clinically ill neonatal foals.
Equine veterinary journal    December 18, 2007   Volume 40, Issue 1 41-44 doi: 10.2746/042516407X235803
Javsicas LH, Sanchez LC.Administration of omeprazole paste per os to healthy neonatal foals has been shown to effectively increase intragastric pH, but has not been evaluated in sick neonatal foals. Objective: To determine the effect of orally administered omeprazole paste on intragastric pH in clinically ill neonatal foals requiring nasogastric intubation. Methods: Intragastric pH was measured continuously for 24 h using an indwelling electrode and continuous data recording system in hospitalised neonatal foals age < or =2 days. Intragastric pH was measured for 12 h prior to (pretreatment period) and 12 h followi...
Pharmacokinetics of voriconazole following intravenous and oral administration and body fluid concentrations of voriconazole following repeated oral administration in horses.
American journal of veterinary research    October 6, 2007   Volume 68, Issue 10 1115-1121 doi: 10.2460/ajvr.68.10.1115
Colitz CM, Latimer FG, Cheng H, Chan KK, Reed SM, Pennick GJ.To determine the pharmacokinetics of voriconazole following IV and PO administration and assess the distribution of voriconazole into body fluids following repeated PO administration in horses. Methods: 6 clinically normal adult horses. Methods: All horses received voriconazole (10 mg/kg) IV and PO (2-week interval between treatments). Plasma voriconazole concentrations were determined prior to and at intervals following administration. Subsequently, voriconazole was administered PO (3 mg/kg) twice daily for 10 days to all horses; plasma, synovial fluid, CSF, urine, and preocular tear film con...
Glossitis and tongue trauma subsequent to administration of an oral medication, using an udder infusion cannula, in a horse.
The Canadian veterinary journal = La revue veterinaire canadienne    September 11, 2007   Volume 48, Issue 8 845-847 
Fuller MC, Abutarbush SM.A 10-year-old gelding was presented with a tongue that had swelled immediately after oral administration of oxfendazole, using an udder infusion cannula. The tongue appeared to have been punctured inadvertently. The horse recovered after treatment with intravenous fluid, antibiotics, and anti-inflammatory drugs. Administering oral medication by this method should be discouraged. Un cheval hongre âgé de 10 ans a été présenté avec une langue devenue tuméfiée immédiatement après l’administration orale d’oxfendazole à l’aide d’une canule à infusion du pis. La langue semblait a...
Pharmacokinetics of acyclovir after intravenous infusion of acyclovir and after oral administration of acyclovir and its prodrug valacyclovir in healthy adult horses.
Antimicrobial agents and chemotherapy    September 10, 2007   Volume 51, Issue 12 4308-4314 doi: 10.1128/AAC.00116-07
Garré B, Shebany K, Gryspeerdt A, Baert K, van der Meulen K, Nauwynck H, Deprez P, De Backer P, Croubels S.The purpose of this study was twofold. The first aim was to evaluate the oral bioavailability and pharmacokinetics (PKs) of acyclovir in horses after intravenous (i.v.) administration and after oral administration of acyclovir and its prodrug, valacyclovir. Second, we aimed to combine these PK data with pharmacodynamic (PD) information, i.e., 50% effective concentrations (EC(50) values) from in vitro studies, to design an optimal dosage schedule. Three treatments were administered to healthy adult horses: 10 mg of acyclovir/kg of body weight delivered as an i.v. infusion over 1 h, 20 mg of acy...
Cetirizine in horses: pharmacokinetics and pharmacodynamics following repeated oral administration.
Veterinary journal (London, England : 1997)    June 19, 2007   Volume 177, Issue 2 242-249 doi: 10.1016/j.tvjl.2007.03.026
Olsén L, Bondesson U, Broström H, Tjälve H, Ingvast-Larsson C.The pharmacokinetics of the histamine H(1)-antagonist cetirizine and its effect on histamine-induced cutaneous wheal formation were studied in six healthy horses following repeated oral administration. After three consecutive administrations of cetirizine (0.2 mg/kg body weight, bw) every 12h, the trough plasma concentration of cetirizine was 16+/-4 ng/mL (mean+/-SD) and the wheal formation was inhibited by 45+/-23%. After four additional administrations of cetirizine (0.4 mg/kg bw) every 12 h, the trough plasma concentration was 48+/-15 ng/mL and the wheal formation was inhibited by 68+/-11%....
Trimetoquinol: bronchodilator effects in horses with heaves following aerosolised and oral administration.
Equine veterinary journal    May 25, 2007   Volume 39, Issue 3 215-220 doi: 10.2746/042516407x173334
Camargo FC, Robinson NE, Berney C, Eberhart S, Baker S, Detolve P, Derksen FJ, Lehner AF, Hughes C, Tobin T.The bronchodilator effects of trimetoquinol (TMQ) have been studied when administered i.v. or intratracheally, but not in an aerosolised form. Objective: To define the relationship between the therapeutic and adverse responses (therapeutic index) of TMQ when administered as an aerosol or by the oral route. Methods: Increasing doses of TMQ were administered to horses with heaves as an aerosol and by the oral route. Dose ranged 100-1000 microg/horse for aerosolised TMQ and from 6-60 microg/kg bwt for the oral route. Airway and cardiac effects were assessed by measurement of maximal change in ple...
Pharmacokinetics of oral doxycycline and concentrations in body fluids and bronchoalveolar cells of foals.
Journal of veterinary pharmacology and therapeutics    May 3, 2007   Volume 30, Issue 3 187-193 doi: 10.1111/j.1365-2885.2007.00857.x
Womble A, Giguère S, Lee EA.The objective of this study was to determine the disposition of orally administered doxycycline in foals. Six healthy 4- to 8-week-old foals were used. Doxycycline was administered to each foal via the intragastric (IG) route at dosages of 10 and 20 mg/kg, in a cross-over design. After the first 10 mg/kg dose, five additional doses were administered at 12-h intervals. A microbiological assay was used to measure doxycycline activity in serum, urine, peritoneal fluid, synovial fluid, cerebrospinal (CSF), pulmonary epithelial lining fluid (PELF), and bronchoalveolar (BAL) cells. Following adminis...
Pharmacokinetics and metabolism of orally administered firocoxib, a novel second generation coxib, in horses.
Journal of veterinary pharmacology and therapeutics    May 3, 2007   Volume 30, Issue 3 208-217 doi: 10.1111/j.1365-2885.2007.00840.x
Kvaternick V, Pollmeier M, Fischer J, Hanson PD.The primary objective of this study was to determine the pharmacokinetic profile of firocoxib, a novel second generation coxib, in horses. Horses were administered either a single oral or intravenous dose of firocoxib at 0.1 mg/kg in a two-period crossover study with 12 animals. The dosage was based on previously determined pharmacodynamic parameters. Oral firocoxib was well absorbed with an average bioavailability (absolute) of 79% and a Cmax of 75 ng/mL at 3.9 h. The average elimination half-life was 30 h. Following intravenous administration the average Cmax was 210 ng/mL and the eliminatio...
Cetirizine in horses: pharmacokinetics and effect of ivermectin pretreatment.
Journal of veterinary pharmacology and therapeutics    May 3, 2007   Volume 30, Issue 3 194-200 doi: 10.1111/j.1365-2885.2007.00850.x
Olsén L, Ingvast-Larsson C, Bondesson U, Broström H, Tjälve H, Larsson P.The pharmacokinetics of the histamine H(1)-antagonist cetirizine and the effects of pretreatment with the antiparasitic macrocyclic lactone ivermectin on the pharmacokinetics of cetirizine were studied in horses. After oral administration of cetirizine at 0.2 mg/kg bw, the mean terminal half-life was 3.4 h (range 2.9-3.7 h) and the maximal plasma concentration 132 ng/mL (101-196 ng/mL). The time to reach maximal plasma concentration was 0.7 h (0.5-0.8 h). Ivermectin (0.2 mg/kg bw) given orally 1.5 h before cetirizine did not affect its pharmacokinetics. However, ivermectin pretreatment 12 h be...
Safety of elevated dosages of a 0.24% diflubenzuron pellet administered orally to horses.
Veterinary therapeutics : research in applied veterinary medicine    April 21, 2007   Volume 8, Issue 1 61-76 
Ross DH, Heird C, Byrd JW, Beauchemin V, Kiess W.The safety of a feed-thru pellet formulation containing the insect growth regulator diflubenzuron (0.24%) for control of manure-breeding flies (Musca domestica L. and Stomoxys calcitrans L.) in horses was evaluated. Pellets were administered orally at 0, 1, 3, and 5 times the clinical dosage (0.12 to 0.20 mg/kg) on a daily basis for 31 consecutive days. Variables examined included daily clinical observations, hematology, coagulation, serum chemistry, acetylcholinesterase inhibition, body weights, and physical examinations. Horses remained healthy throughout the study, and no adverse reactions ...
Clinical pharmacokinetics of oseltamivir and its active metabolite oseltamivir carboxylate after oral administration in horses.
The Journal of veterinary medical science    April 6, 2007   Volume 69, Issue 3 293-296 doi: 10.1292/jvms.69.293
Yamanaka T, Yamada M, Tsujimura K, Kondo T, Nagata S, Hobo S, Kurosawa M, Matsumura T.The aim of this study was to investigate the pharmacokinetics of oseltamivir carboxylate (OC) in horses (n=6) after oral administration of its prodrug oseltamivir. The binding rate of OC to horse plasma proteins was negligible (<1%). Oral administration of oseltamivir of 2 mg/kg body weight of oseltamivir to horses provided a plasma concentration of OC (mean maximum concentration: 257.9 ng/ml) above the inhibitory concentrations against equine influenza A viruses determined in vitro. However, because OC is rapidly eliminated from horse plasma (mean elimination half-life: 2.5 hr), administratio...
1 11 12 13 14 15 26